Struggling to ensure your patients receive the full support they need?

Unpack the impact a Lung Cancer Clinical Nurse Specialist can have on your organisation. Learn how to craft a strong business case and secure funding for this vital role.

Read more > buff.ly/4aXNc4W

The July 2024 PBAC agenda is available with submissions closing on Wednesday 29 May 2024.

Submissions are welcome whether you are a patient, carer, member of the public, health professional or member of a consumer interest grou
Read the agenda buff.ly/3xKLhCt

Here's your chance to hear how you can work together to ensure the best cancer care for all patients 🤝

Watch for this upcoming episode of the IASLC podcast Lung Cancer Considered where I discuss #KRAS beyond G12C with Drs. Mariana Brandao and Raj Veluswamy. What's on the horizon for KRAS G12V, G12D, and others?

Play an active part in the scientific program by presenting your work at the 2024 TOGA ASM

🏆 Awards and prizes will be available for successful abstract presentations

Submit > buff.ly/3VdR7pZ

Here is your reminder that the National Lung Cancer Screening Program is only 14 months away! Launching in July 2025, it will offer free scans to high-risk patients to improve patient outcomes with early detection.
Educate yourself and your patients > buff.ly/3Jb7xrZ

Let's all get around Alex Davis to support him as he gets ready to run the City2Surf 👟

TOGA would like to welcome Tracey Leong as this year's ASM Convenor.

NEW FUNDING OPPORTUNITY 💰 MRFF - 2024 International Clinical Trial Collaborations Grant Opportunity

Max Funding $3 Million
Close date: 31 July 2024

Learn More > buff.ly/3PdUdXb

Oncologists from around Australia are looking forward to gathering in Sydney for Medical Oncology Group of Australia 45th Annual Scientific Meeting.
Date: 14-16 August
Location: ICC, Sydney
Register now to attend!

Quick 🏃‍♀️ Registrations close today!

In the 1980s, evidence demonstrating the impact of 2nd hand smoke on #lungcancer incidence grew. One of the earliest studies was by Dr. Hirayama in Japan, demonstrating a risk factor of 2 for developing lung cancer in never-smoking women if their husbands smoked. #LCSM #IASLC50

ACTA, together with ACEM, are providing a workshop on developing cross-network collaborations and collaborating with a network to do research together.

Date: Tuesday, April 9
Time: 3:00 PM - 4:30 PM
Register now: lnkd.in/gKsNR76w

New Funding Opportunity: Gilead Australia Fellowship Grants Program

Gilead is accepting applications focused on improving the care and outcomes of people living with lung cancer via a variety of projects.

Funding: $60,000
Close date: 26 April

buff.ly/47rvKVy

Living with #ALKpositive lung cancer? Help advance ALK+ lung cancer research through the ENIGMA+ study: go2.org/research/our-r…